BlackRock’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

BlackRock’s Portfolio PRNB Stock Details PRNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,643,059	Closed	-$158M	–	5223
2020 Q2	$158M	Buy	2,643,059 +684,203	+35%	+$42.3M	0.01%	1522
2020 Q1	$116M	Buy	1,958,856 +87,899	+5%	+$5.12M	0.01%	1543
2019 Q4	$102M	Buy	1,870,957 +769,378	+70%	+$28.7M	﹤0.01%	1944
2019 Q3	$31.1M	Buy	1,101,579 +119,364	+12%	+$4.38M	﹤0.01%	2564
2019 Q2	$32.6M	Buy	982,215 +535,495	+120%	+$16.7M	﹤0.01%	2569
2019 Q1	$15.2M	Buy	446,720 +4,054	+0.9%	+$129K	﹤0.01%	2891
2018 Q4	$12.1M	Buy	442,666 +293,166	+196%	+$7.55M	﹤0.01%	2986
2018 Q3	$4.37M	Buy	+149,500	New	+$4.22M	﹤0.01%	3536

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ADL

Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

BlackRock's PRNB Position: Q3 2020 in Review

BlackRock sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 2,643,059 shares — an estimated $158M sold.

BlackRock first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $158M in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

BlackRock reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
BlackRock sold 2,643,059 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $158M.
BlackRock first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
BlackRock's Principia Biopharma Inc. Common Stock position peaked at $158M in Q2 2020.
9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.